# Ernexa Therapeutics Inc.: Form SC 13D, filed May 13, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D
- Filed: 2021-05-13
- Accepted by EDGAR: May 13, 2021, 17:00 ET
- Period: not reported
- Accession: 0001140361-21-017257
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121017257/brhc10024476_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121017257/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121017257/brhc10024476_sc13d.htm

Filed May 13, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-017257. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
